Social Determinants of Health Impact Poststroke Mortality Risk
By Lori Solomon HealthDay Reporter
MONDAY, May 20, 2024 -- Social determinants of health have a cumulative impact on poststroke mortality, according to a study presented at the the annual European Stroke Organization Conference, held from May 15 to 17 in Basel, Switzerland.
Katharina Stibrant Sunnerhagen, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues investigated if there is an association between social determinants of health and stroke mortality. The analysis included data from local and national stroke registries, Statistics Sweden, and the National Patient Registry.
The researchers found that among 6,901 individuals with stroke, a higher education was associated with a 25.7 percent lower risk for death versus primary education, and individuals with high income had a 32.3 percent lower risk for death versus those with low income. Neither living in a deprived area nor country of birth was significantly associated with mortality. There was an association observed between increased mortality and lifestyle factors (physical inactivity, diabetes, and alcohol abuse) and atrial fibrillation. A dose-response relationship was noted, with individuals with one determinant having a 17.5 percent increased risk for mortality and those with two to four determinants having a 24.3 percent increased risk.
"By addressing these disparities, we will not only support the principles of health equity, but also have the potential to significantly enhance public health outcomes," Stibrant Sunnerhagen said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.